You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer

 

Online download statistics by month:

Online download statistics by month: January 2020 to March 2024

AbstractFullPdf
Jan 202012120
Feb 202023230
Mar 202042421
Apr 202026263
May 2020343415
Jun 202034347
Jul 2020303014
Aug 2020343233
Sep 2020585829
Oct 2020646424
Nov 2020585921
Dec 2020484810
Jan 2021777726
Feb 2021929235
Mar 2021717130
Apr 2021565633
May 2021606025
Jun 2021494922
Jul 2021575731
Aug 2021343413
Sep 2021515118
Oct 2021505036
Nov 2021363634
Dec 2021444419
Jan 2022495523
Feb 2022414327
Mar 2022515644
Apr 2022394114
May 2022566424
Jun 2022353617
Jul 2022353817
Aug 202232326
Sep 2022596323
Oct 2022373719
Nov 2022454524
Dec 2022373816
Jan 2023485131
Feb 2023353711
Mar 202311411429
Apr 2023454635
May 2023151515
Jun 2023333313
Jul 2023272714
Aug 2023232316
Sep 202327278
Oct 2023323214
Nov 2023333323
Dec 2023202011
Jan 2024222217
Feb 2024323221
Mar 2024606023
Total222222591014